A carregar...

Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) Tumor Biomarker for Identifying Recurrent Disease in African American Patients

Evaluation of prostate cancer prognosis after surgery is increasingly relying upon genomic analyses of tumor DNA. We assessed the ability of the biomarker panel Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) to predict biochemical recurrence in 33 European American and 28 African American...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Levin, Albert M., Lindquist, Karla J., Avila, Andrew, Witte, John S., Paris, Pamela L., Rybicki, Benjamin A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119547/
https://ncbi.nlm.nih.gov/pubmed/24891551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-13-1124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!